Thorsten Graef

VP, Clinical Science, Pharmacyclics.

Companies

Artiva Biotherapeutics, Inc.Chief Medical Officer Jul 18, 2024 to Feb 28, 2025¹
PharmacyclicsVP, Clinical Science Jul 10, 2013 to Nov 6, 2013²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Artiva Biotherapeutics, Inc. ARTV80,000 shares³$468.0K at $5.85Feb 26, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 26, 2025Granted 60,000 shares of Artiva Biotherapeutics, Inc.³
Sep 12, 2024Granted 20,000 shares of Artiva Biotherapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARArtiva Biotherapeutics, Inc., Chief Medical Officer
2
SEC EDGARPharmacyclics, VP, Clinical Science
3
SEC EDGARArtiva Biotherapeutics, Inc. shares after the filing of Feb 26, 2025
4
SEC EDGARForm 4 filed Sep 13, 2024